Everest Group, Ltd. (EG) — Fundamental Analysis & Key Financial Ratios

Kaplio's reading: Everest Group, Ltd.

Updated on October 3, 2026 · accounts published on July 29, 2026

Reading of October 3, 2026: A steadily profitable insurer with low leverage and a growing dividend

Everest trades at 1.0× book value and a P/E of 7.8× over the last 12 months, 42 % below the median of its insurance sector.

• Is Everest expensive or cheap? Everest trades at 1.0× book with a 12.4 % ROE, and its P/E of 7.8× is 42 % below the sector median of 13.5×.
• How is the business doing? Operating margin reached 15.4 % over the last 12 months, well above the 11.6 % average of fiscal 2014-2025.
• How strong is the balance sheet? Debt is 0.23 times equity over the last 12 months, and the dividend has risen for 11 consecutive fiscal years.
• What to expect from the next earnings? Everest reports on October 28, 2026; analysts expect EPS of $8.56, and the 2026 EPS consensus edged up 0.6 % to $53.88.
• Does Everest underwrite with discipline and build book value? Book value per share grew 8.8 % a year in fiscal 2020-2025, just above the 8 % bar considered healthy for insurers.

Is Everest expensive or cheap?

For an insurer, price to book comes first. Everest trades at 1.0× book value over the last 12 months while earning a ROE of 12.4 %. That is a mid-range return, and for it up to 1.5× book is usually considered healthy. The P/E points the same way. At 7.8× trailing earnings, an earnings yield of 11.2 %, it is 17 % below its ten-year median of 9.4× and 42 % below the sector median of 13.5×. Over the past decade it traded cheaper only 25 % of the time. The shares are up 6 % over 12 months and sit 8 % below their 52-week high of $398.70.

How is the business doing?

Profits have grown much faster than sales. Revenue rose just 1.4 % over the last 12 months, but EPS climbed 19.1 %. The trailing operating margin of 15.4 % is well above both fiscal 2025 (11.3 %) and the 11.6 % average of fiscal 2014-2025. Net margin stands at 11.5 % and ROE at 12.4 %. The open question is whether this lasts. Insurance margins swing from year to year, and the five-year average of 10.7 % is a more sober reference than one strong trailing period. With sales almost flat, the jump in earnings has come with very little help from growth.

How strong is the balance sheet?

Everest carries little leverage. Debt to equity was 0.23 over the last 12 months, below the 0.3 level considered prudent for insurers. That matters in a business that must keep capital ready to pay claims. The dividend yields 2.2 % over the last 12 months and has grown for 11 straight fiscal years through 2025, just past the 10-year bar for an insurance dividend aristocrat. With a payout of 21 % of fiscal 2025 earnings, the dividend takes only a small share of profits. Most of the earnings stay in the company to build capital and book value.

What to expect from the next earnings?

Expectations are steady and edging higher. Over the last 18 days the 2026 EPS consensus rose 0.6 %, from $53.54 to $53.88 across 9 analysts, while the revenue estimate barely moved. For the quarter to be reported on October 28, 2026, analysts expect EPS of $8.56. That is well below the $14.85 delivered on July 29, 2026, which beat the $14.52 estimate by 2.3 %. The track record is mixed: Everest beat EPS estimates in 4 of the last 8 quarters. Of 22 analysts, 8 rate the stock a buy, 14 a hold and none a sell.

Does Everest underwrite with discipline and build book value?

Insurers make money in two ways: underwriting well and investing the float, the model Buffett used to build Berkshire. Underwriting results are lumpy, so the useful tests look at multi-year averages and at book value. Everest's operating margin averaged 10.7 % over fiscal 2021-2025, just above the 10 % healthy threshold. Book value per share compounded at 8.8 % a year in fiscal 2020-2025, close to the 8 % floor. All five sector checks pass, including leverage, P/B and the dividend record, but the two operating tests pass only narrowly. If the margin held nearer the trailing 15.4 %, those tests would pass by a much wider margin.

How this was prepared: the data comes from companies' official filings, collected by a professional provider, and from Kaplio's analysis engine (trailing-12-month ratios, 10 years of history and sector medians computed across US-listed companies). The text is written from that data alone, every figure is checked against it before publication, and it is reviewed when the company reports results. This is not investment advice.